Shaked, S., Rokach, L., Arbel, R., Razi, T. and Tadmor, T. (2026) “Glucagon-like peptide-1 receptor agonist exposure is associated with lower secondary malignancy risk during watch-and-wait in chronic lymphocytic leukemia: a timevarying analysis”, Haematologica. Pavia, Italy. doi: 10.3324/haematol.2026.301905.